Kopaciewicz L[au] - Search Results

Year	Number of Results
1980	1
1985	1
1986	1
1988	3
1989	1
1991	1
1994	1
2022	0

1

A new model of myocardial infarction in Yucatan minipigs.

Hamburger SA, Kopaciewicz LJ, Valocik RE. Hamburger SA, et al. Among authors: kopaciewicz lj. J Pharmacol Methods. 1991 Jul;25(4):291-301. doi: 10.1016/0160-5402(91)90029-5. J Pharmacol Methods. 1991. PMID: 1886415

2

Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion.

Fong KL, Crysler CS, Mico BA, Boyle KE, Kopia GA, Kopaciewicz L, Lynn RK. Fong KL, et al. Among authors: kopaciewicz l. Drug Metab Dispos. 1988 Mar-Apr;16(2):201-6. Drug Metab Dispos. 1988. PMID: 2898333

3

Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries.

Kopia GA, Kopaciewicz LJ, Ruffolo RR Jr. Kopia GA, et al. Among authors: kopaciewicz lj. J Pharmacol Exp Ther. 1986 Dec;239(3):641-7. J Pharmacol Exp Ther. 1986. PMID: 2879028

4

Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose-response study.

Kopia GA, Kopaciewicz LJ, Ruffolo RR Jr. Kopia GA, et al. Among authors: kopaciewicz lj. J Pharmacol Exp Ther. 1988 Mar;244(3):956-62. J Pharmacol Exp Ther. 1988. PMID: 3252043

5

Evaluation of the acute hemodynamic effects and pharmacokinetics of coronary thrombolysis produced by intravenous tissue-type plasminogen activator in the anesthetized dog.

Kopia GA, Kopaciewicz LJ, Fong KL, Crysler CS, Boyle K, Ruffolo RR Jr. Kopia GA, et al. Among authors: kopaciewicz lj. J Cardiovasc Pharmacol. 1988 Sep;12(3):308-16. doi: 10.1097/00005344-198809000-00008. J Cardiovasc Pharmacol. 1988. PMID: 2464103

6

Prostaglandin stimulation of canine platelet adenylate cyclase.

Longenecker GL, Kopaciewicz LJ, Palmer SJ, Palmer GC. Longenecker GL, et al. Among authors: kopaciewicz lj. Thromb Res. 1980 Jul 1-15;19(1-2):119-24. doi: 10.1016/0049-3848(80)90410-7. Thromb Res. 1980. PMID: 7444848 No abstract available.

7

The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonist.

Nichols AJ, Vasko JA, Valocik RE, Kopaciewicz LJ, Storer BL, Ali FE, Romoff T, Calvo R, Samanen JM. Nichols AJ, et al. Among authors: kopaciewicz lj. Thromb Res. 1994 Jul 15;75(2):143-56. doi: 10.1016/0049-3848(94)90063-9. Thromb Res. 1994. PMID: 7974388

8

Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.

Kopia GA, Kopaciewicz LJ, Ohlstein EH, Horohonich S, Storer BL, Shebuski RJ. Kopia GA, et al. Among authors: kopaciewicz lj. J Pharmacol Exp Ther. 1989 Sep;250(3):887-95. J Pharmacol Exp Ther. 1989. PMID: 2528630

9

Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.

Shebuski RJ, Fujita T, Smith JM Jr, Kopaciewicz LJ, Blumberg AL, Hieble JP. Shebuski RJ, et al. Among authors: kopaciewicz lj. J Pharmacol Exp Ther. 1985 Dec;235(3):735-40. J Pharmacol Exp Ther. 1985. PMID: 2867207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results